Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome

Andrea Angeletti; Maurizio Bruschi; Manuela Colucci; Xhuliana Kajana; Edoardo La Porta; Gianluca Caridi; Francesca Lugani; Pietro Ravani; Marina Vivarelli; Paolo Cravedi; Gian Marco Ghiggeri

doi:10.1016/j.ekir.2022.08.006

Circulating Anti-Rituximab Antibodies Do Not Affect Response to Rituximab in Steroid-Dependent Nephrotic Syndrome

Kidney Int Rep. 2022 Aug 20;7(11):2509-2512. doi: 10.1016/j.ekir.2022.08.006. eCollection 2022 Nov.

Authors

Affiliations

¹ Division of Nephrology, Dialysis, and Transplantation, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
² Laboratory on Molecular Nephrology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
³ Renal Diseases Research Unit, Genetics and Rare Diseases Division, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
⁴ Division of Nephrology, University of Calgary, Calgary, Alberta, Canada.
⁵ Division of Nephrology, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
⁶ Translational Transplant Research Center, Renal Division, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

No abstract available

Keywords: anti-rituximab antibodies; focal segmental glomerulosclerosis; monoclonal anti-CD20 antibodies; nephrotic syndrome; rituximab; steroid-dependent nephrotic syndrome.